Insider · CIK 0001970151
Brian Birchler
Files at IONS (IONIS PHARMACEUTICALS INC). First filing Jan 17, 2025, latest Nov 7, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IONS: IONIS PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | IONIS PHARMACEUTICALS INC | $609k 8,000 shares | -14% | +190% from low-1% from high | |
| 23Weak | IONIS PHARMACEUTICALS INC | $1.7M 23,900 shares | -35% | +180% from low0% from high | |
| 15Weak | IONIS PHARMACEUTICALS INC | $19k 680 shares | -1% | +11% from low-34% from high | |
| 27Weak | IONIS PHARMACEUTICALS INC | $177k 5,400 shares | -9% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +58 | $51.31 | $2,976 | 102,883 | 40 d ago |
| Nov 6, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -8,000 | $76.17 | $609k | 48,826 | Nov 7, 2025 |
| Oct 14, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +11,475 | $53.77 | $617k | 68,301 | Oct 16, 2025 |
| Oct 14, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -11,475 | $72.03 | $827k | 56,826 | Oct 16, 2025 |
| Oct 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +12,425 | $53.77 | $668k | 69,251 | Oct 16, 2025 |
| Oct 15, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -12,425 | $72.23 | $897k | 56,826 | Oct 16, 2025 |
| Oct 14, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -11,475 | $0.00 | $0 | 12,425 | Oct 16, 2025 |
| Oct 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -12,425 | $0.00 | $0 | 0 | Oct 16, 2025 |
| Aug 29, 2025 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +166 | $27.71 | $4,600 | 56,826 | Sep 3, 2025 |
| Apr 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +1,875 | $0.00 | $0 | 57,340 | Apr 17, 2025 |
| Apr 16, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -680 | $28.37 | $19k | 56,660 | Apr 17, 2025 |
| Apr 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -1,875 | $0.00 | $0 | 61,215 | Apr 17, 2025 |
| Feb 28, 2025 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +414 | $28.21 | $12k | 55,465 | Mar 4, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +14,283 | $0.00 | $0 | 60,451 | Jan 17, 2025 |
| Jan 16, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -5,400 | $32.70 | $177k | 55,051 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Performance Restricted Stock Unitsderivative | +22,000 | $0.00 | $0 | 53,338 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +33,000 | $0.00 | $0 | 77,373 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -14,283 | $0.00 | $0 | 63,090 | Jan 17, 2025 |
| Jan 2, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.